Jian Xie - 23 Feb 2025 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
President and COO
Signature
/s/ Paul Kim as Attorney-in-Fact
Issuer symbol
FLGT
Transactions as of
23 Feb 2025
Transactions value $
-$11,835
Form type
4
Filing time
25 Feb 2025, 17:26:37
Previous filing
28 Jan 2025
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Tax liability -$11.8K -719 -0.22% $16.46 329K 23 Feb 2025 Direct F1
holding FLGT Common Stock 221K 23 Feb 2025 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.
F2 Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.